EUVIMEDEUVIMED entdecken
Crossref

Development of UiO‐66 and ZIF‐8 MOF Nanocarriers for Anticancer Drug Delivery in Breast Cancer Cells

Anulipsa Priyadarshini, Deepak Senapati, Niharika Das, Sonali Gupta, Jaykishon Swain, Debadutta Samal, K C Barick, Rojalin Sahu iD

Chemistry – An Asian Journal · 2025

DOI: 10.1002/asia.202500672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Anulipsa Priyadarshini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Future Materials Laboratory, Department of chemistry, School of Applied Sciences, Kalinga Institute of Industrial Technology (deemed to be university…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Doxorubicin, Drug Carriers, Zeolites. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal‐organic frameworks (MOFs), characterized by their extensive surface area, biocompatibility, and pH‐sensitive degradation have emerged as promising candidates for drug delivery systems (DDSs). This study focused on the development of zinc based zeolitic imidazolate framework (ZIF8) and zirconium‐based framework (UiO‐66) MOFs as effective nanocarriers for delivery of broad‐spectrum chemotherapeutic drug, doxorubicin hydrochloride (DOX), aiming to mitigate adverse side effects in breast cancer treatment. The nanocarriers, ZIF‐8 and UiO‐66 achieved a maximum drug loading efficiency of about between 79% and 75% at a drug‐to‐particle ratio of 1:10, and exhibited their pH‐responsive release, which is essential for cancer therapy. The in vitro therapeutic efficacy of developed DDSs was explored on breast cancer (MCF‐7 and MDA‐MB‐231) cell lines as well lung normal cells (WI26VA4). From confocal microscopic studies, it has been observed that a substantial amount of DOX is internalized into the cancer cells in a time‐dependent manner. It is noteworthy to mention that both the developed drug formulations (DOX@UiO‐66 and DOX@ZIF‐8) showed dose‐dependent toxicity towards cancer cell lines. Moreover, the cell viability studies performed with pure ZIF‐8 and UiO‐66 MOFs against normal as well as cancer cells demonstrated their biocompatibility nature even at a high concentration of 50 µg/mL. These findings underscore the potential of ZIF‐8 and UiO‐66 MOFs as effective and biocompatible platforms for drug delivery in breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksDoxorubicinDrug CarriersZeolitesBreast NeoplasmsAntineoplastic AgentsImidazolesZirconiumNanoparticlesHumansFemaleCell SurvivalDrug LiberationDrug Screening Assays, AntitumorCell Line, TumorCell ProliferationDrug Delivery SystemsMCF-7 CellsPhthalic Acids

Stichwörter der Autor:innen

BiocompatibleCancer therapyCell viabilityDOXMOFsNanocarriers

Substanzen

Metal-Organic FrameworksDoxorubicinDrug CarriersZeolitesAntineoplastic AgentsImidazolesUiO-66ZirconiumZIF-8 metal-organic frameworkPhthalic Acids

Autor:innen und Institutionen

  • Future Materials Laboratory, Department of chemistry, School of Applied Sciences, Kalinga Institute of Industrial Technology (deemed to be university), Bhubaneswar, Odisha, 751024, India.
  • Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.
  • Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.

ORCID-Profile: Rojalin Sahu

Zitieren

APA

Priyadarshini, A., Senapati, D., Das, N., Gupta, S., Swain, J., Samal, D., Barick, K. C., & Sahu, R. (2025). Development of UiO‐66 and ZIF‐8 MOF Nanocarriers for Anticancer Drug Delivery in Breast Cancer Cells. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202500672

Vancouver

Priyadarshini A, Senapati D, Das N, Gupta S, Swain J, Samal D, et al. Development of UiO‐66 and ZIF‐8 MOF Nanocarriers for Anticancer Drug Delivery in Breast Cancer Cells. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202500672

BibTeX
@article{Priyadarshini2025,
  author = {Priyadarshini, Anulipsa and Senapati, Deepak and Das, Niharika and Gupta, Sonali and Swain, Jaykishon and Samal, Debadutta and Barick, K C and Sahu, Rojalin},
  title = {Development of UiO‐66 and ZIF‐8 MOF Nanocarriers for Anticancer Drug Delivery in Breast Cancer Cells},
  journal = {Chemistry – An Asian Journal},
  year = {2025},
  doi = {10.1002/asia.202500672}
}
Kostenlos starten →